Your browser doesn't support javascript.
loading
The status of combination therapy for visceral leishmaniasis: an updated review.
van Griensven, Johan; Dorlo, Thomas Pc; Diro, Ermias; Costa, Carlos; Burza, Sakib.
Affiliation
  • van Griensven J; Institute of Tropical Medicine, Antwerp, Belgium. Electronic address: jvangriensven@itg.be.
  • Dorlo TP; Department of Pharmacy, Uppsala University, Uppsala, Sweden; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Diro E; Department of General Internal Medicine, University of Washington, Seattle, WA, USA.
  • Costa C; Intelligence Center on Emerging and Neglected Tropical Diseases and Injuries, Federal University of Piauí, Teresina, Brazil.
  • Burza S; Médecins Sans Frontières, New Delhi, India; London School of Hygiene and Tropical Medicine, London, UK.
Lancet Infect Dis ; 24(1): e36-e46, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37640031
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Screening_studies Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Screening_studies Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Country of publication: